# Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antitumor-activity-and-pharmacokinetic-properties-of-pf-00299804-a-second/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Andrea J. Gonzales,Kenneth E. Hook,Irene W. Althaus,Paul A. Ellis,Erin Trachet,Amy M. Delaney,Patricia J. Harvey,Teresa A. Ellis,Danielle M. Amato,James M. Nelson,David W. Fry,Tong Zhu,Cho‐Ming Loi,Stephen A. Fakhoury,Kevin M. Schlosser,Karen E. Sexton,R. Thomas Winters,Jessica E. Reed,Alex Bridges,Daniel J. Lettiere,Deborah A. Baker,Jianxin Yang,Helen T. Lee,Haile Tecle,Patrick W. Vincent |
| Citations | 221 |
| DOI | 10.1158/1535-7163.mct-07-2232 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/mct/article-pdf/7/7/1880/1880250/1880.pdf |
| OpenAlex ID | https://openalex.org/W2112098753 |
| PMID | 18606718 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Jianxin Yang](https://scholariq.org/researchers/jianxin-yang/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.